Ocumension Therapeutics (HKSE:01477) Pre-Tax Income : HK$-349.9 Mil (TTM As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Ocumension Therapeutics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Ocumension Therapeutics's pretax income for the six months ended in Jun. 2024 was HK$-162.6 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-349.9 Mil. Ocumension Therapeutics's pretax margin was -90.13%.

During the past 6 years, Ocumension Therapeutics's highest Pretax Margin was -103.99%. The lowest was -699018.96%. And the median was -463.06%.

Ocumension Therapeutics Pre-Tax Income Historical Data

The historical data trend for Ocumension Therapeutics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocumension Therapeutics Pre-Tax Income Chart

Ocumension Therapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

-1,474.93

-2,684.85

-318.35

-449.18

-415.07

Ocumension Therapeutics Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Pre-Tax Income	Get a 7-Day Free Trial							-225.42	-234.42	-227.79	-187.27	-162.64

Competitive Comparison of Ocumension Therapeutics's Pre-Tax Income

For the Biotechnology subindustry, Ocumension Therapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ocumension Therapeutics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocumension Therapeutics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Ocumension Therapeutics's Pre-Tax Income falls into.

Ocumension Therapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Ocumension Therapeutics's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-438.977	+	0	+	-1.449	+	23.976	+	1.383
	=	-415.1

Ocumension Therapeutics's Pretax Income for the quarter that ended in Jun. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-172.171	+	0	+	-1.967	+	15.378	+	-3.88
	=	-162.6

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-349.9 Mil.

Ocumension Therapeutics (HKSE:01477) Pre-Tax Income Explanation

Ocumension Therapeutics's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-162.64	/	180.453
	=	-90.13%

During the past 6 years, Ocumension Therapeutics's highest Pretax Margin was -103.99%. The lowest was -699018.96%. And the median was -463.06%.

Ocumension Therapeutics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Ocumension Therapeutics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Ocumension Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocumension Therapeutics (HKSE:01477) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

5DG:Germany

Address

No. 1858 Yinzhongnan Road, Guoxiang Subdistrict, Wuzhong District, Suzhou, Jiangsu, CHN

Website

https://www.ocumension.com

Ocumension Therapeutics is an ophthalmic pharmaceutical platform company identifying, developing, and commercializing ophthalmic therapies. It provides a pharmaceutical total solution to address unmet ophthalmic medical needs in China. Its product candidates include OT-401 (YUTIQ), OT-101, OT-301 (NCX 470), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-202, OT-503 (NCX 4251), OT-701, Ou Qin, Brimonidine tartrate eye drop, 0.5% moxifloxacin eye drop, OT-601-C, OT-302, OT-1301, T-1601, and OT-1602.

Executives

Liu Ye	2101 Beneficial owner
6 Dimensions Capital, L.p.	2101 Beneficial owner
Zhang Qiping	2201 Interest of corporation controlled by you
Su Zhou Fu Yan Chuang Ye Tou Zi Guan Li He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
6 Dimensions Capital Gp, Llc	2201 Interest of corporation controlled by you
Su Zhou Tong He Er Qi Chuang Ye Tou Zi He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Su Zhou Yun Zhang Tou Zi Zi Xun You Xian Gong Si	2201 Interest of corporation controlled by you
Boyu Capital Fund Iv, L.p.	2201 Interest of corporation controlled by you
Boyu Capital Group Holdings Ltd	2201 Interest of corporation controlled by you
Boyu Capital General Partner Iv, Ltd	2201 Interest of corporation controlled by you
Summer Iris Limited	2101 Beneficial owner
Alcon Pharmaceuticals Ltd	2101 Beneficial owner
Alcon Inc.	2201 Interest of corporation controlled by you
Temasek Holdings (private) Limited	2201 Interest of corporation controlled by you
The Capital Group Companies, Inc.	2201 Interest of corporation controlled by you

Ocumension Therapeutics Headlines

No Headlines